Clover Health Investments (CLOV) Cash from Investing Activities (2020 - 2026)

Clover Health Investments has reported Cash from Investing Activities for 7 years, with the latest figure at -$5.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 156.75% year-over-year to -$5.1 million; the trailing twelve-month figure through Mar 2026 stood at -$9.9 million (down 3300.65% YoY), and the FY2025 full-year result was $4.1 million, up 621.42% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$5.1 million, up from -$35.0 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $89.4 million in Q2 2022, with the low at -$43.4 million in Q3 2022.
• Historically, Cash from Investing Activities has averaged $13.8 million across 5 years, with a median of $8.9 million in 2025.
• The largest YoY upside for Cash from Investing Activities was 617.92% in 2025 against a maximum downside of 2331.9% in 2025.
• Clover Health Investments' Cash from Investing Activities stood at $12.7 million in 2022, then soared by 561.05% to $83.7 million in 2023, then tumbled by 101.72% to -$1.4 million in 2024, then sank by 2331.9% to -$35.0 million in 2025, then jumped by 85.52% to -$5.1 million in 2026.
• The last three Cash from Investing Activities figures came in at -$5.1 million (Q1 2026), -$35.0 million (Q4 2025), and -$5.4 million (Q3 2025), per Business Quant data.